Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Tivic Health Systems Inc. (TIVC:NASDAQ), powered by AI.
Tivic Health Systems Inc. is currently trading at $0.56. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Tivic Health Systems Inc. on Alpha Lenz.
View Tivic Health Systems Inc.'s valuation metrics on Alpha Lenz.
“Tivic Health Systems Inc.'s ROE is -91.8%. Explore profitability and growth together.”
Ask for details →Tivic Health Systems Inc. is a technology-driven health company focused on developing and commercializing bioelectronic medicine and therapeutic devices. The primary function of this company is to utilize its advanced platforms and technology to create non-invasive medical treatments aimed at improving quality of life and reducing reliance on pharmaceuticals. Tivic Health Systems Inc. is particularly impactful in sectors such as healthcare innovation, medical technology, and wellness industries. Its flagship product, ClearUP Sinus Pain Relief, exemplifies the company’s dedication to non-drug treatments, offering consumers a clinically validated solution for sinus pain using microcurrent technology. Founded to pioneer advancements in personal medical devices, Tivic Health Systems places a strong emphasis on research and development, ensuring their products meet regulatory standards and consumer needs. By doing so, Tivic contributes significantly to the growing field of bioelectronic medicine, appealing to a market seeking alternative health solutions and efficiency in managing chronic conditions. This positions Tivic Health at the intersection of technology and healthcare, facilitating improved personal health management strategies.
“Tivic Health Systems Inc.'s ROE is -91.8%. Explore profitability and growth together.”
Ask for details →Tivic Health Systems Inc. (ticker: TIVC) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 7 employees.
The current price is $0.559 with a P/E ratio of -x and P/B of -x.
ROE is -91.85%.